Last $499.52 USD
Change Today -1.04 / -0.21%
Volume 205.1K
ISRG On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

intuitive surgical inc (ISRG) Snapshot

Open
$501.46
Previous Close
$500.56
Day High
$504.41
Day Low
$498.05
52 Week High
04/3/14 - $541.23
52 Week Low
05/9/14 - $346.46
Market Cap
18.3B
Average Volume 10 Days
184.0K
EPS TTM
$13.13
Shares Outstanding
36.6M
EX-Date
--
P/E TM
38.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for INTUITIVE SURGICAL INC (ISRG)

intuitive surgical inc (ISRG) Details

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States, Europe, and Asia. Its da Vinci surgical system translates a surgeon’s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci surgical system comprise a surgeon’s console, a patient-side cart, a 3-D vision system, da Vinci skills simulator, and Firefly fluorescence imaging product that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments consisting of forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci single-site instruments and accessories that allow da Vinci Si surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler 45 instruments, which are wristed stapling instruments intended for resection, transection and/or creation of anastomoses in general, gynecologic, and urologic surgery, as well as sells various accessory products, including sterile drapes for ensuring a sterile field during surgery, replacement 3-D stereo endoscopes, camera heads, light guides, and other items used in conjunction with the da Vinci surgical system. Intuitive Surgical, Inc. markets its products directly and through distributors. The company was founded in 1995 and is headquartered in Sunnyvale, California.

2,978 Employees
Last Reported Date: 02/6/15
Founded in 1995

intuitive surgical inc (ISRG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $560.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $391.4K
Executive Vice President of Global Commercial...
Total Annual Compensation: $400.0K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $380.0K
Principal Accounting Officer and Vice Preside...
Total Annual Compensation: $227.6K
Compensation as of Fiscal Year 2013.

intuitive surgical inc (ISRG) Key Developments

Intuitive Surgical, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 09:50 AM

Intuitive Surgical, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 09:50 AM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States.

Intuitive Surgical, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year of 2015

Intuitive Surgical, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total revenue of USD 604.7 million against USD 576.2 million a year ago. Income from operations was USD 186.1 million against USD 208.6 million a year ago. Income before taxes was USD 184.8 million against USD 214.5 million a year ago. Net income was USD 146.8 million or USD 3.94 per diluted share against USD 166.2 million or USD 4.28 per diluted share a year ago. Non-GAAP revenue was USD 600.8 million against USD 576.2 million a year ago. Non-GAAP income from operations was USD 237 million against USD 254.9 million a year ago. Non-GAAP income per diluted share was USD 4.92 against USD 4.98 a year ago. Non-GAAP net income was USD 183.5 million against USD 193.4 million a year ago. The company generated an operating profit of USD 237 million in the quarter before noncash stock compensation expense, down 8% from the fourth quarter of last year. For the year, the company reported total revenue of USD 2,131.7 million against USD 2,265.1 million a year ago. Income from operations was USD 544.8 million against USD 852.5 million a year ago. Income before taxes was USD 549.0 against USD 870.9 million a year ago. Net income was USD 418.8 million or USD 11.11 per diluted share against USD 671 million or USD 16.73 per diluted share a year ago. Non-GAAP income from operations was USD 818.7 million against USD 1,042.7 million a year ago. Non-GAAP income per diluted share was USD 16.10 against USD 19.83 a year ago. Non-GAAP net income was USD 606.9 million against USD 795 million a year ago. The company generated USD 819 million in operating profit before noncash stock option expense, down 21% from last year. The company expects pro forma effective rate for 2015 will reflect a more normal range of 28% to 30%. The tax rate will fluctuate with changes in mix of U.S. and OUS income, and will not reflect a federal research and development credit, unless such credit is reinstated. The company expects 2015 pro forma gross profit margin to be fairly consistent with fourth quarter of 2014. The company expects to grow pro forma 2015 operating expenses between 7% and 10% above 2014 levels.

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2014

Intuitive Surgical, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2014. The company expects GAAP revenue for the fourth quarter of 2014 of approximately $605 million, up approximately 5% from $576 million for the fourth quarter of 2013. The company expects non-GAAP revenue for the fourth quarter of 2014 of approximately $601 million, which excludes approximately $4 million of revenue associated with da Vinci Xi trade-out offers. Preliminary fourth quarter 2014 GAAP service revenue is expected to increase approximately 6% to approximately $110 million from $103 million during the fourth quarter of 2013. The company expects GAAP revenue for the year ended December 31, 2014 to total approximately $2.1 billion, down approximately 6% from $2.3 billion for the year ended December 31, 2013. Preliminary full year 2014 service revenue is expected to increase approximately 8% to approximately $429 million from $397 million during 2013. For the year, the company expects non-GAAP revenue of $2,131.7 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISRG:US $499.52 USD -1.04

ISRG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $72.51 USD +0.61
CR Bard Inc $170.28 USD +2.62
Edwards Lifesciences Corp $135.65 USD -0.11
Endo International PLC $87.71 USD +2.06
Hologic Inc $32.44 USD +0.08
View Industry Companies
 

Industry Analysis

ISRG

Industry Average

Valuation ISRG Industry Range
Price/Earnings 45.1x
Price/Sales 8.6x
Price/Book 5.4x
Price/Cash Flow 43.7x
TEV/Sales 8.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTUITIVE SURGICAL INC, please visit www.intuitivesurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.